Tarsus Pharmaceuticals (TARS) PT Raised to $45 as Jefferies Sees Possibility of First Line Therapy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: TARS) | Delayed: 73.92 +1.87 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.05 | 52 Week High | $ | |||
| Open | $72.90 | 52 Week Low | $ | |||
| Day High | $74.76 | P/E | N/A | |||
| Day Low | $72.74 | EPS | $ | |||
| Volume | 49,917 | |||||
